6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF A FOREIGN ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For April 18, 2007

ASML Holding N.V.

De Run 6501

5504 DR Veldhoven

The Netherlands

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  þ                    Form 40-F  o

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  o                    No  þ

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
 

THIS REPORT ON FORM 6-K IS INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-13332), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-105600), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-109154), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-116337), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-126340), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-136362) AND THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-141125) OF ASML HOLDING N.V.

TABLE OF CONTENTS

Exhibit 99.1

Exhibit 99.2

Exhibit 99.3

Exhibits

99.1	“ASML Announces 2007 First Quarter Results; Confirming Growth for 2007,” press release dated April 18, 2007
99.2	Summary U.S. GAAP Consolidated Statements of Operations
99.3	Summary IFRS Consolidated Statements of Operations

     “Safe Harbor” Statement under the U.S. Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements that are subject to risks and uncertainties including, but not limited to, economic conditions, product demand and industry capacity, competitive products and pricing, manufacturing efficiencies, new product development, ability to enforce patents, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, and other risks indicated in filings with the U.S. Securities and Exchange Commission.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ASML HOLDING N.V. (Registrant)
Date: April 19, 2007	By:	/s/ Peter T.F.M. Wennink
		Peter T.F.M. Wennink
		Executive Vice President and Chief Financial Officer

2

EX-99.1

Exhibit 99.1

ASML Announces 2007 First Quarter Results;
Confirming Growth for 2007

VELDHOVEN, the Netherlands, April 18, 2007 — ASML Holding NV (ASML) today announced 2007 first quarter results according to US GAAP as follows:

• Q1 2007 net sales of EUR 960 million versus Q4 2006 net sales of EUR 1,068 million and Q1 2006 net sales of 629 million, 53% growth year on year

• Q1 2007 net income of EUR 153 million or 16.0 percent of sales — which includes EUR 25 million costs for the Brion acquisition, of which EUR 23 million is a one-off charge — versus Q4 2006 net income of EUR 206 million or 19.3 percent of sales and Q1 2006 net income of EUR 80 million or 12.7 percent of sales

• Q1 2007 net bookings valued at EUR 911 million with 62 systems including 59 new and 3 refurbished systems, leading to an order backlog valued at EUR 2,163 million as of April 1, 2007

“High-value bookings in Q1 underline the robustness of our position in the market. Orders from foundry and logic customers compensated for the expected slowdown in flash and DRAM orders and resulted in a record backlog,” said Eric Meurice, president and CEO, ASML. “This backlog will ensure a sustained sales level in Q2, and strong revenues in the second half of the year supported by the need for capacity from foundry and IDM customers, and continuing immersion bookings. We therefore confirm our view that 2007 will be a growth year for ASML.”

Operations Update

In Q1 2007, ASML net sales were EUR 960 million, as ASML shipped 66 new and 11 refurbished systems, totaling sales of EUR 859 million, and generated revenue from field options and service of EUR 101 million. Net sales for Q4 2006 included the shipment of 64 new and 8 refurbished machines, totaling EUR 979 million, plus revenue from field and service options of EUR 89 million.

1

The Q1 2007 average selling price (ASP) for a new system was EUR 12.5 million, compared with the Q4 2006 average selling price for a new system of EUR 14.7 million, due to a higher number of mid range systems in the mix. The Q1 2007 average selling price for all ASML systems sold was EUR 11.2 million, compared with the Q4 2006 average selling price of EUR 13.6 million.

Q1 2007 net bookings totaled 62 systems valued at EUR 911 million, including 59 new systems with an average selling price for new systems of EUR 15.2 million. ASML’s order backlog as of April 1, 2007 is valued at EUR 2,163 million, totaling 148 systems with an average selling price of EUR 14.6 million. In comparison, ASML’s backlog as of December 31, 2006 was valued at EUR 2,146 million, totaling 163 systems with an average selling price of EUR 13.2 million.

In Q1 2007, ASML generated a net income of EUR 153 million or EUR 0.32 per ordinary share including EUR 25 million costs for the Brion acquisition, of which EUR 23 million is a one-off charge. In comparison, the net income Q4 2006 was EUR 206 million or EUR 0.43 per ordinary share.

The company’s Q1 2007 gross margin was 40.9 percent, compared with the Q4 2006 gross margin of 41.1 percent.

Q1 2007 research and development (R&D) costs were EUR 116 million net of credits. The Q4 2006 R&D costs were EUR 107 million net of credits.

Selling, general and administrative (SG&A) expenses were EUR 56 million in Q1 2007, while the Q4 2006 SG&A expenses were EUR 52 million.

The effective tax rate was 25.9% in Q1 2007, compared to 28.0% in Q4 2006. The decrease in effective tax rate is mainly related to a decrease in the statutory tax rate in the Netherlands from 29.6% in 2006 to 25.5% in 2007.

2

Net cash from operations was EUR 173 million in Q1 2007. ASML ended Q1 2007 with EUR 1,463 million in cash and equivalents versus EUR 1,656 million at the end of Q4 2006. The decrease is due to the share buyback program executed in Q1 2007 as well as the Brion acquisition.

The Brion acquisition was successfully completed in Q1 2007. As previously disclosed, ASML paid EUR 203 million in cash to acquire Brion, EUR 66 million thereof has been allocated to assets, including the 23 million for ongoing R&D, the remainder is booked as goodwill.

Outlook

“ASML has shipped over 40 immersion tools to date, and has reported 24 immersion systems in backlog. Several tools shipped are already producing flash memory in volume,” said Eric Meurice. “Leading manufacturers are using our systems in production for the 65 nm node, ramping 55 nm node and progressing development of 45 nm, for which the XT:1700i is the only available lithography tool in the market. With over 100,000 wafers-per-month now processed on ASML immersion tools, customers are engineering dedicated production processes, solidifying ASML’s long term leadership, in view of the significant investment and risk necessary to switch architectures. Our new XT:1900i, due for shipment early Q3, has already imaged at 36.5 nm, and its performance is on track. This confirms our leadership position and we anticipate a further improvement of our market share in 2007 as a result.”

The company plans to ship 69 systems in Q2 2007 with an average selling price of EUR 12.0 million for all systems. The revenue from field options and service will be about EUR 100 million. The company expects a gross margin in Q2 2007 from 40 to 41 percent.

Almost all systems in the backlog are to be shipped this year with 78% of the unit backlog carrying Q2 2007 and Q3 2007 shipment dates.

ASML continues not to guide on future bookings as leadtime uncertainties linked to new technology ramps make a bookings timing-call difficult. However, ASML does confirm that revenue growth is expected for the year.

3

We expect R&D expenditures to increase to EUR 120 million net of credits in Q2 2007. SG&A expenses in Q2 2007 are expected to remain at EUR 56 million.

ASML reiterates its commitment to return excess cash to shareholders by reducing the number of shares outstanding. The Annual General Meeting of Shareholders which took place on March 28, 2007 has authorized the company to prepare for additional potential share buyback programs. Further information will be disclosed in due course.

About ASML

ASML is the world’s leading provider of lithography systems for the semiconductor industry, manufacturing complex machines that are critical to the production of integrated circuits or chips. Headquartered in Veldhoven, the Netherlands, ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. For more information, visit the Web site at ASML.com

IFRS Financial Reporting

ASML’s primary accounting standard for quarterly earnings releases and annual reports is US GAAP, the accounting standard generally accepted in the United States. Quarterly US GAAP statements of operations, statements of cash flows and balance sheets, and a reconciliation of net income and equity from US GAAP to IFRS are available on ASML.com

In addition to reporting financial figures in US GAAP, ASML also reports financial figures in IFRS for statutory purposes. The most significant differences between US GAAP and IFRS that affect ASML concern the capitalization of certain product development costs, the accounting of stock option plans and the accounting of existing convertible bonds. Quarterly IFRS statements of operations, statements of cash flows, balance sheets and a reconciliation of net income and equity from US GAAP to IFRS are available on ASML.com

Investor and Media Call

A conference call for investors and media will be hosted by CEO Eric Meurice and CFO Peter Wennink at 15:00 PM Central European Time / 09:00 AM Eastern U.S. time. Dial-in numbers are: in the Netherlands +31 20 531 5871 and the US +1 706 679 0473. Access is also via ASML.com to listen to the conference call.

A presentation about 2007 First Quarter results is available on ASML.com

4

Forward Looking Statements

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements that are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development, ability to enforce patents, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

Media Relations Contacts

Angelique Paulussen — Corporate Communications — +31 40 268 6572 — Veldhoven, the Netherlands

Investor Relations Contacts

Craig DeYoung — Investor Relations — +1 480 383 4005 — Tempe, Arizona
Franki D’Hoore — Investor Relations — +31 40 268 6494 — Veldhoven, the Netherlands

5

EX-99.2

Exhibit 99.2

ASML — Summary U.S. GAAP Consolidated Statements of Operations¹

	Three months ended,
	Apr 2, 2006			Apr 1, 2007
(Amounts in thousands EUR except per share data)
Net system sales		553,101			858,948
Net service sales		76,289			101,295
Net sales		629,390			960,243
Cost of sales		377,769			567,644
Gross profit		251,621			392,599
Research and development costs, net of credits		87,011			116,442
Amortization of in process R&D		—			23,148
Selling, general and administrative expenses		50,267			56,330
Total expenses		137,278			195,920
Operating income		114,343			196,679
Financial income (expense), net		(4,376	)		10,260
Income before income taxes		109,967			206,939
Provision for income taxes		(29,933	)		(53,639	)
Net income		80,034			153,300
Basic net income per ordinary share		0.17			0.32
Diluted net income per ordinary share		0.16	2		0.31	2
Number of ordinary shares used in computing per share amounts (in thousands):
Basic		484,984			473,573
Diluted		545,732	2		502,613	2

ASML — Ratios and Other Data¹

	Three months ended,
	Apr 2, 2006		Apr 1, 2007
Gross profit as a % of net sales		40.0		40.9
Operating income as a % of net sales		18.2		20.5
Net income as a % of net sales		12.7		16.0
Shareholders’ equity as a % of total assets		47.3		53.5
Income taxes as a % of income before income taxes		27.2		25.9
Sales of new systems (units)		39		66
Sales of used systems (units)		12		11
Sales of systems total (units)		51		77
Backlog new systems (units)		94		146
Backlog used systems (units)		12		2
Backlog systems total (units)		106		148
Net bookings new systems (units)		47		59
Net bookings used systems (units)		15		3
Net bookings total (units)		62		62
Number of employees		5,088		5,975

ASML — Summary U.S. GAAP Consolidated Balance Sheets¹

	Apr 2, 2006		Apr 1, 2007
(Amounts in thousands EUR)
ASSETS
Cash and cash equivalents		1,671,065		1,463,212
Accounts receivable, net		447,401		648,608
Inventories, net		940,423		906,710
Other current assets		208,007		310,492
Total current assets		3,266,896		3,329,022
Other assets		240,568		216,435
Intangible assets		23,197		194,560
Property, plant and equipment		278,114		288,522
Total assets		3,808,775		4,028,539
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,385,057		1,221,305
Convertible subordinated bonds		380,039		380,000
Long term debt and deferred liabilities		243,285		270,762
Shareholders’ equity		1,800,394		2,156,472
Total liabilities and Shareholders’ equity		3,808,775		4,028,539

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows¹

	Three months ended,
	Apr 2, 2006			Apr 1, 2007
(Amounts in thousands EUR)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		80,034			153,300
Depreciation and amortization		22,118			50,431
Change in tax assets and liabilities		(53,550	)		30,909
Change in assets and liabilities		(267,638	)		(61,343	)
Net cash provided by (used in) operating activities		(219,036	)		173,297
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment		(16,919	)		(35,789	)
Proceeds from sale of property, plant and equipment		693			4,306
Purchase of intangible assets		—			(201,669	)
Acquired financial fixed assets		—			744
Acquired cash		—			6,127
Net cash used in investing activities		(16,226	)		(226,281	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Purchase of shares		—			(156,253	)
Proceeds from issuance of shares and stock options		7,858			18,073
Excess tax benefits from stock options		—			627
Redemption and/or repayment of loans		(310	)		(234	)
Net cash provided by (used in) financing activities		7,548			(137,787	)
Net cash flow		(227,714	)		(190,771	)
Effect of changes in exchange rates on cash		(5,830	)		(1,874	)
Net decrease in cash & cash equivalents		(233,544	)		(192,645	)

ASML — Quarterly Summary U.S. GAAP Consolidated Statements of Operations¹

	Three months ended,
	Apr 2,			Jul 2,			Oct 1,			Dec 31,			Apr 1,
	2006			2006			2006			2006			2007
(Amounts in millions EUR)
Net system sales		553.1			840.8			856.5			978.6			858.9
Net service sales		76.3			100.9			101.9			88.9			101.3
Net sales		629.4			941.7			958.4			1,067.5			960.2
Cost of sales		377.8			560.8			567.5			628.9			567.6
Gross profit		251.6			380.9			390.9			438.6			392.6
Research and development costs, net of credits		87.0			92.3			100.3			106.9			116.5
Amortization of in process R&D		—			—			—			—			23.1
Selling, general and administrative expenses		50.3			51.0			51.4			52.1			56.3
Total expenses		137.3			143.3			151.7			159.0			195.9
Operating income		114.3			237.6			239.2			279.6			196.7
Financial income (expense), net		(4.3	)		(1.9	)		(0.4	)		5.7			10.3
Income before income taxes		110.0			235.7			238.8			285.3			207.0
Provision for income taxes		(30.0	)		(68.6	)		(66.8	)		(79.8	)		(53.7	)
Net income		80.0			167.1			172.0			205.5			153.3

ASML — Quarterly Summary Ratios and other data¹

	Three months ended,
	Apr 2,		Jul 2,		Oct 1,		Dec 31,		Apr 1,
	2006		2006		2006		2006		2007
Gross profit as a % of net sales		40.0		40.4		40.8		41.1		40.9
Operating income as a % of net sales		18.2		25.2		25.0		26.2		20.5
Net income as a % of net sales		12.7		17.7		17.9		19.3		16.0
Shareholders’ equity as a % of total assets		47.3		42.1		45.2		54.6		53.5
Income taxes as a % of income before income taxes		27.2		29.1		28.0		28.0		25.9
Sales of new systems (units)		39		58		59		64		66
Sales of used systems (units)		12		14		12		8		11
Sales of systems total (units)		51		72		71		72		77
Backlog new systems (units)		94		114		143		153		146
Backlog used systems (units)		12		13		8		10		2
Backlog systems total (units)		106		127		151		163		148
Value of backlog new systems (EUR million)		1,560		1,785		2,099		2,120		2,157
Value of backlog used systems (EUR million)		36		45		27		26		6
Value of backlog systems total (EUR million)		1,596		1,830		2,126		2,146		2,163
Net bookings new systems (units)		47		78		88		74		59
Net bookings used systems (units)		15		15		7		10		3
Net bookings total (units)		62		93		95		84		62
Number of employees		5,088		5,209		5,388		5,594		5,975

ASML — Summary U.S. GAAP Consolidated Balance Sheets¹

	Apr 2,		Jul 2,		Oct 1,		Dec 31,		Apr 1,
	2006		2006		2006		2006		2007
(Amounts in millions EUR)
ASSETS
Cash and cash equivalents		1,671.1		1,731.5		1,580.9		1,655.9		1,463.2
Accounts receivable, net		447.4		540.3		674.5		672.7		648.6
Inventories, net		940.4		916.2		837.2		808.5		906.7
Other current assets		208.0		220.7		263.8		288.9		310.5
Total current assets		3,266.9		3,408.7		3,356.4		3,426.0		3,329.0
Other assets		240.6		218.0		196.9		236.0		216.4
Intangible assets		23.2		21.5		19.7		18.1		194.6
Property, plant and equipment		278.1		287.0		281.5		270.9		288.5
Total assets		3,808.8		3,935.2		3,854.5		3,951.0		4,028.5
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,385.1		1,655.6		1,518.6		1,181.4		1,221.3
Convertible subordinated bonds		380.0		380.0		380.0		380.0		380.0
Long term debt and deferred liabilities		243.3		242.2		214.4		233.1		270.7
Shareholders’ equity		1,800.4		1,657.4		1,741.5		2,156.5		2,156.5
Total liabilities and Shareholders’ equity		3,808.8		3,935.2		3,854.5		3,951.0		4,028.5

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows¹

	Three months ended,
	Apr 2,			Jul 2,			Oct 1,			Dec 31,			Apr 1,
	2006			2006			2006			2006			2007
(Amounts in millions EUR)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		80.0			167.1			172.0			205.5			153.3
Depreciation and amortization		22.1			20.7			29.6			32.0			50.4
Change in tax assets and liabilities		(53.5	)		65.3			61.8			(45.2	)		30.9
Change in assets and liabilities		(267.6	)		76.9			(261.2	)		172.0			(61.3	)
Net cash provided by (used in) operating activities		(219.0	)		330.0			2.2			364.3			173.3
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment		(16.9	)		(14.0	)		(16.6	)		(23.1	)		(35.8	)
Proceeds from sale of property, plant and equipment		0.7			0.7			1.3			2.5			4.3
Purchases of intangible assets		—			—			—			(0.1	)		(201.6	)
Acquired financial fixed assets		—			—			—			—			0.7
Acquired cash		—			—			—			—			6.1
Net cash used in investing activities		(16.2	)		(13.3	)		(15.3	)		(20.7	)		(226.3	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Purchase of shares		—			(252.6	)		(148.1	)		(277.6	)		(156.3	)
Proceeds from issuance of shares and stock options		7.8			6.8			9.4			13.5			18.1
Excess tax benefits from stock options		—			—			—			1.1			0.6
Redemption and/or repayment of loans		(0.3	)		(0.3	)		(0.3	)		(7.4	)		(0.2	)
Net cash provided by (used in) financing activities		7.5			(246.1	)		(139.0	)		(270.4	)		(137.8	)
Net cash flow		(227.7	)		70.6			(152.1	)		73.2			(190.8	)
Effect of changes in exchange rates on cash		(5.8	)		(10.2	)		1.5			1.8			(1.9	)
Net increase (decrease) in cash & cash equivalents		(233.5	)		60.4			(150.6	)		75.0			(192.7	)

1.)	Except for balance sheet data as of December 31, 2006, all figures are unaudited.
2.)	The calculation of diluted net income per ordinary share assumes conversion of our Subordinated Notes as such conversions would have a dilutive effect.

ASML — Notes to the Summary U.S. GAAP Consolidated Financial Statements

Basis of Presentation

ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. The accompanying consolidated financial statements are stated in thousands of euros (‘EUR’).

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranty is recognized in income on a straight-line basis over the contract period except in those circumstances in which sufficient historical evidence indicates that the costs of performing services under the contract are incurred on other than a straight-line basis. In those circumstances, revenue is recognized over the contract period in proportion to the costs expected to be incurred in performing services under the contract. The costs of providing services under extended and enhanced warranty are recognized when they occur.

Stock options

On January 1, 2006, ASML implemented the provisions of Statement of Financial Accounting Standards No. 123(R), “Share-Based Payment” (SFAS 123(R)), using the modified prospective transition method. SFAS 123(R) requires companies to recognize the cost of employee services received (compensation costs) in exchange for awards of equity instruments based upon the grant-date fair value of those instruments. Using the modified prospective transition method of adopting SFAS 123(R), ASML began recognizing compensation cost for equity-based awards granted, modified, repurchased, or cancelled after the required effective date of January 1, 2006. Additionally, compensation cost for the portion of equity-based awards for which the requisite service has

not been rendered that are outstanding as of January 1, 2006 are also recognized as the requisite service is rendered on or after that date. Compensation costs are then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period.

The compensation cost for that portion of awards is based on the grant-date fair value of those awards as calculated under SFAS 123 “Accounting for Stock-Based Compensation” for pro forma disclosures.

Under the modified prospective transition method, no restatement of prior interim periods and fiscal years has been made. Prior to January 1, 2006, ASML measured compensation cost for its stock option plans using the intrinsic value method under APB 25 “Accounting for stock issued to employees” and related interpretations. As the exercise price of all stock options granted under these plans was not below the fair market price of the underlying common stock on the grant date, no compensation costs were recognized in the consolidated statements of operations.

ASML — Reconciliation U.S. GAAP — IFRS¹

Net income

	Three months ended,
	Apr 2, 2006			Apr 1, 2007
(Amounts in thousands EUR)
Net income under U.S. GAAP		80,034			153,300
Share-based Payments (see Note 1)		309			121
Capitalization of development costs (see Note 2)		12,186			22,683
Convertible Subordinated Notes (see Note 3)		(7,690	)		(2,176	)
Other (see Note 4)		—			(7,648	)
Net income under IFRS		84,839			166,280

Shareholders’ Equity

	Apr 2,		Jul 2,		Oct 1,		Dec 31,		Apr 1,
	2006		2006		2006		2006		2007
(Amounts in thousands EUR)
Shareholders’ equity under U.S. GAAP		1,800,394		1,657,449		1,741,492		2,156,455		2,156,472
Share-based Payments (see Note 1)		2,460		2,095		5,269		343		523
Capitalization of development costs (see Note 2)		64,002		74,314		80,848		90,769		113,451
Convertible Subordinated Notes (see Note 3)		47,529		39,751		32,524		31,416		29,239
Other (see Note 4)		—		—		—		—		—
Shareholders’ equity under IFRS		1,914,385		1,773,609		1,860,133		2,278,983		2,299,685

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments
Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options granted to its employees after November 7, 2002.

Under U.S. GAAP, until December 31, 2005, ASML accounted for stock option plans using the intrinsic value method in accordance with APB 25 “Accounting for stock issued to employees” and provided pro forma disclosure of the impact of the fair value method on net income and earnings per share in accordance with SFAS No. 123 “Accounting for Stock Based Compensation”. As of January 1, 2006, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments.

Note 2 Capitalization of development costs
Under IFRS, ASML applies IAS 38, “Intangible Assets”. During the second half of 2004, ASML made changes to its administrative systems in order to provide sufficient information to comply with IFRS beginning from January 1, 2005. Sufficient reliable information to account for capitalization of development expenditures under IFRS before January 1, 2005 is not available. Under IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between 2 and 3 years. Amortization starts when the developed product is ready for volume production.

Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Convertible Subordinated Notes
Under IFRS, ASML applies IAS 32 “Financial instruments: Disclosure and presentation” and IAS 39 “Financial instruments: Recognition and measurement” beginning from January 1, 2005. In accordance with IAS 32 and IAS 39, ASML accounts separately for the equity and liability component of its convertible notes (“Split accounting”). The equity component relates to the grant of a conversion option to shares to the holder of the bond. Split accounting results in additional interest charges.

Under U.S. GAAP, ASML accounts for its convertible bonds as a liability at the principal amount outstanding.

Note 4 Other
Other differences between IFRS and U.S. GAAP mainly relate to a different accounting treatment of income tax.

“Safe Harbor” Statement under the U.S. Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements that are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development, ability to enforce patents, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission.

EX-99.3

Exhibit 99.3

ASML — Summary IFRS Consolidated Statements of Operations¹

	Three months ended,
	Apr 2, 2006			Apr 1, 2007
(Amounts in thousands EUR)
Net system sales		553,101			858,948
Net service sales		76,289			101,294
Net sales		629,390			960,242
Cost of sales		383,330			590,894
Gross profit		246,060			369,348
Research and development costs, net of credits		64,132			93,658
Selling, general and administrative expenses		50,239			56,156
Total expenses		114,371			149,814
Operating income		131,689			219,534
Financial income (expense), net		(15,246	)		7,316
Income before income taxes		116,443			226,850
Provision for income taxes		(31,604	)		(60,570	)
Net income		84,839			166,280

ASML — Summary IFRS Consolidated Balance Sheets¹

	Apr 2, 2006		Apr 1, 2007
(Amounts in thousands EUR)
ASSETS
Cash and cash equivalents		1,671,065		1,463,212
Accounts receivable, net		447,401		648,608
Inventories, net		940,423		906,710
Other current assets		113,209		169,638
Total current assets		3,172,098		3,188,168
Other assets		307,515		326,392
Intangible assets		114,109		339,008
Property, plant and equipment		278,114		288,522
Total assets		3,871,836		4,142,090
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,365,383		1,163,876
Convertible subordinated bonds		324,248		336,477
Long term debt and deferred liabilities		267,820		342,052
Shareholders’ equity		1,914,385		2,299,685
Total liabilities and Shareholders’ equity		3,871,836		4,142,090

ASML — Summary IFRS Consolidated Statements of Cash Flows¹

	Three months ended,
	Apr 2, 2006			Apr 1, 2007
(Amounts in thousands EUR)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		84,839			166,280
Depreciation and amortization		26,882			73,298
Change in tax assets and liabilities		(52,133	)		31,247
Change in assets and liabilities		(256,279	)		(51,981	)
Net cash provided by (used in) operating activities		(196,691	)		218,844
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment		(16,919	)		(35,789	)
Proceeds from sale of property, plant and equipment		693			4,306
Purchase of intangible assets		(22,345	)		(247,216	)
Acquired financial fixed assets		—			744
Acquired cash		—			6,127
Net cash used in investing activities		(38,571	)		(271,828	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Purchase of shares		—			(156,253	)
Proceeds from issuance of shares and stock options		7,858			18,073
Excess tax benefits from stock options		—			627
Redemption and/or repayment of loans		(310	)		(234	)
Net cash provided by (used in) financing activities		7,548			(137,787	)
Net cash flow		(227,714	)		(190,771	)
Effect of changes in exchange rates on cash		(5,830	)		(1,874	)
Net decrease in cash and cash equivalents		(233,544	)		(192,645	)

ASML — Quarterly Summary IFRS Consolidated Statements of Operations¹

	Three months ended,
	Apr 2,			Jul 2,			Oct 1,			Dec 31,			Apr 1,
	2006			2006			2006			2006			2007
(Amounts in millions EUR)
Net system sales		553.1			840.8			856.5			978.6			858.9
Net service sales		76.3			100.9			101.9			88.9			101.3
Net sales		629.4			941.7			958.4			1,067.5			960.2
Cost of sales		383.3			568.0			582.0			649.6			590.9
Gross profit		246.1			373.7			376.4			417.9			369.3
Research & development costs, net of credits		64.1			71.0			76.5			78.6			93.7
Selling, general and administrative expenses		50.3			50.4			51.4			52.3			56.1
Total expenses		114.4			121.4			127.9			130.9			149.8
Operating income		131.7			252.3			248.5			287.0			219.5
Financial income (expense), net		(15.3	)		(12.8	)		(10.8	)		1.6			7.3
Income before income taxes		116.4			239.5			237.7			288.6			226.8
Provision for income taxes		(31.6	)		(69.9	)		(64.8	)		(79.9	)		(60.5	)
Net income		84.8			169.6			172.9			208.7			166.3

ASML — Summary IFRS Consolidated Balance Sheets¹

	Apr 2,		Jul 2,		Oct 1,		Dec 31,		Apr 1,
	2006		2006		2006		2006		2007
(Amounts in millions EUR)
ASSETS
Cash and cash equivalents		1,671.1		1,731.5		1,580.9		1,655.8		1,463.2
Accounts receivable, net		447.4		540.3		674.5		672.8		648.6
Inventories, net		940.4		916.2		837.2		808.5		906.7
Other current assets		113.2		126.8		157.5		147.7		169.7
Total current assets		3,172.1		3,314.8		3,250.1		3,284.8		3,188.2
Other assets		307.5		289.9		285.4		346.5		326.4
Intangible assets		114.1		127.0		134.5		139.9		339.0
Property, plant and equipment		278.1		287.0		281.5		270.9		288.5
Total assets		3,871.8		4,018.7		3,951.5		4,042.1		4,142.1
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,365.4		1,657.2		1,530.6		1,181.9		1,163.9
Convertible subordinated bonds		324.2		328.1		332.1		333.2		336.5
Long term debt and deferred liabilities		267.8		259.8		228.7		248.0		342.0
Shareholders’ equity		1,914.4		1,773.6		1,860.1		2,279.0		2,299.7
Total liabilities and Shareholders’ equity		3,871.8		4,018.7		3,951.5		4,042.1		4,142.1

ASML — Summary IFRS Consolidated Statements of Cash Flows¹

	Three months ended,
	Apr 2,			Jul 2,			Oct 1,			Dec 31,			Apr 1,
	2006			2006			2006			2006			2007
(Amounts in millions EUR)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		84.8			169.6			172.9			208.7			166.3
Depreciation and amortization		26.9			26.0			43.9			52.7			73.3
Change in tax assets and liabilities		(52.1	)		66.6			58.2			(47.7	)		31.2
Change in assets and liabilities		(256.3	)		88.0			(249.0	)		178.5			(52.0	)
Net cash provided by (used in) operating activities		(196.7	)		350.2			26.0			392.2			218.8
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment		(16.9	)		(14.0	)		(16.6	)		(23.1	)		(35.8	)
Proceeds from property, plant and equipment		0.7			0.7			1.4			2.5			4.3
Purchases of intangible assets		(22.4	)		(20.2	)		(23.9	)		(28.0	)		(247.2	)
Acquired financial fixed assets		—			—			—			—			0.8
Acquired cash		—			—			—			—			6.1
Net cash used in investing activities		(38.6	)		(33.5	)		(39.1	)		(48.6	)		(271.8	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Purchase of shares		—			(252.6	)		(148.1	)		(277.6	)		(156.3	)
Proceeds from issuance of shares and stock options		7.9			6.8			9.4			13.5			18.1
Excess tax benefits from stock options		—			—			—			1.1			0.6
Redemption and/or repayment of loans		(0.3	)		(0.3	)		(0.3	)		(7.4	)		(0.2	)
Net cash provided by (used in) financing activities		7.6			(246.1	)		(139.0	)		(270.4	)		(137.8	)
Net cash flow		(227.7	)		70.6			(152.1	)		73.2			(190.8	)
Effect of changes in exchange rates on cash		(5.8	)		(10.2	)		1.5			1.8			(1.8	)
Net increase (decrease) in cash and cash equivalents		(233.5	)		60.4			(150.6	)		75.0			(192.6	)

1.) Except for balance sheet data as of December 31, 2006 all figures are unaudited.

ASML — Notes to the Summary IFRS Consolidated Financial Statements

Basis of Presentation
ASML has prepared the accompanying summary consolidated financial statements in accordance with International Financial Reporting Standards (“IFRS”) as adopted by the EU — accounting principles generally accepted in the Netherlands for companies quoted on Euronext Amsterdam. Further disclosures, as required under IFRS in annual reports and interim reporting (IAS 34), are not included. The accompanying consolidated financial statements are stated in thousands of euros (‘EUR’), except otherwise indicated.

For internal and external reporting purposes, ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). U.S. GAAP is ASML’s primary accounting standard for the Company’s setting of financial and operational performance targets.

Principles of consolidation
The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates
The preparation of ASML’s consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues
ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment and revenue recognition from the installation of a system upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of the deferred elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and over the life of the contract respectively. Revenue from extended and enhanced warranty is recognized in income on a straight-line basis over the contract period except in those circumstances in which sufficient historical evidence indicates that the costs of performing services under the contract are incurred on other than a straight-line basis. In those circumstances, revenue is recognized over the contract period in proportion to the costs expected to be incurred in performing services under the contract. The costs of providing services under extended and enhanced warranty are recognized when occurred.

Pensions
Under IFRS, ASML applies IAS 19, “Employee benefits”, in accounting for its multi-employer defined benefit plans. In accordance with IAS 19, ASML accounts for its multi-employer defined benefit plan as if it were a defined contribution plan, as the multi-employer union managing the plan, informed ASML that:

• its internal administrative systems are not organized to provide ASML with the required Company-specific information to enable ASML to account for the plan as a defined benefit plan; and

• that it will not provide any data with respect to the multi-employer pension fund other than it is required to make publicly available via its annual report.

ASML — Reconciliation U.S. GAAP — IFRS¹

Net income

	Three months ended,
	Apr 2, 2006			Apr 1, 2007
(Amounts in thousands EUR)
Net income under U.S. GAAP		80,034			153,300
Share-based Payments (see Note 1)		309			121
Capitalization of development costs (see Note 2)		12,186			22,683
Convertible Subordinated Notes (see Note 3)		(7,690	)		(2,176	)
Other (see Note 4)		—			(7,648	)
Net income under IFRS		84,839			166,280

Shareholders’ Equity

	Apr 2,		Jul 2,		Oct 1,		Dec 31,		Apr 1,
	2006		2006		2006		2006		2007
(Amounts in thousands EUR)
Shareholders’ equity under U.S. GAAP		1,800,394		1,657,449		1,741,492		2,156,455		2,156,472
Share-based Payments (see Note 1)		2,460		2,095		5,269		343		523
Capitalization of development costs (see Note 2)		64,002		74,314		80,848		90,769		113,451
Convertible Subordinated Notes (see Note 3)		47,529		39,751		32,524		31,416		29,239
Other (see Note 4)		—		—		—		—		—
Shareholders’ equity under IFRS		1,914,385		1,773,609		1,860,133		2,278,983		2,299,685

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments
Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options granted to its employees after November 7, 2002.

Under U.S. GAAP, until December 31, 2005, ASML accounted for stock option plans using the intrinsic value method in accordance with APB 25 “Accounting for stock issued to employees” and provided pro forma disclosure of the impact of the fair value method on net income and earnings per share in accordance with SFAS No. 123 “Accounting for Stock Based Compensation”. As of January 1, 2006, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments.

Note 2 Capitalization of development expenditures
Under IFRS, ASML applies IAS 38, “Intangible Assets”. During the second half of 2004, ASML made changes to its administrative systems in order to provide sufficient information to comply with IFRS beginning from January 1, 2005. Sufficient reliable information to account for capitalization of development expenditures under IFRS before January 1, 2005 is not available. Under IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between 2 and 3 years. Amortization starts when the developed product is ready for volume production.

Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Convertible Subordinated Notes
Under IFRS, ASML applies IAS 32 “Financial instruments: Disclosure and presentation” and IAS 39 “Financial instruments: Recognition and measurement” beginning from January 1, 2005. In accordance with IAS 32 and IAS 39, ASML accounts separately for the equity and liability component of its convertible notes (“Split accounting”). The equity component relates to the grant of a conversion option to shares to the holder of the bond. Split accounting results in additional interest charges. Under U.S. GAAP, ASML accounts for its convertible bonds as a liability at the principal amount outstanding.

Note 4 Other
Other differences between IFRS and U.S. GAAP mainly relate to a different accounting treatment of income tax.

“Safe Harbor” Statement under the U.S. Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements that are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development, ability to enforce patents, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission.